Friday, January 04, 2013 9:05:35 AM
Johnson & Johnson $JNJ is raised to Buy from Hold with an $82 price target, up from $75, at Deutsche Bank, which cites improving sales trends and benefits of diversification. Recent and new drugs should continue to drive pharma sales, and JNJ should continue to work through the McNeil Consent Decree and return consumer products to market.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
